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Background: A long non-coding RNA (lncRNA), nuclear-enriched abundant transcript 1_2 (NEAT1_2), constitutes
nuclear bodies known as “paraspeckles”. Mutations of RNA binding proteins, including TAR DNA-binding protein-43
(TDP-43) and fused in sarcoma/translocated in liposarcoma (FUS/TLS), have been described in amyotrophic lateral
sclerosis (ALS). ALS is a devastating motor neuron disease, which progresses rapidly to a total loss of upper and
lower motor neurons, with consciousness sustained. The aim of this study was to clarify the interaction of
paraspeckles with ALS-associated RNA-binding proteins, and to identify increased occurrence of paraspeckles in the
nucleus of ALS spinal motor neurons.
Results: In situ hybridization (ISH) and ultraviolet cross-linking and immunoprecipitation were carried out to
investigate interactions of NEAT1_2 lncRNA with ALS-associated RNA-binding proteins, and to test if paraspeckles
form in ALS spinal motor neurons. As the results, TDP-43 and FUS/TLS were enriched in paraspeckles and bound to
NEAT1_2 lncRNA directly. The paraspeckles were localized apart from the Cajal bodies, which were also known to
be related to RNA metabolism. Analyses of 633 human spinal motor neurons in six ALS cases showed NEAT1_2
lncRNA was upregulated during the early stage of ALS pathogenesis. In addition, localization of NEAT1_2 lncRNA
was identified in detail by electron microscopic analysis combined with ISH for NEAT1_2 lncRNA. The observation
indicating specific assembly of NEAT1_2 lncRNA around the interchromatin granule-associated zone in the nucleus
of ALS spinal motor neurons verified characteristic paraspeckle formation.
Conclusions: NEAT1_2 lncRNA may act as a scaffold of RNAs and RNA binding proteins in the nuclei of ALS motor
neurons, thereby modulating the functions of ALS-associated RNA-binding proteins during the early phase of ALS.
These findings provide the first evidence of a direct association between paraspeckle formation and a neurodegenerative
disease, and may shed light on the development of novel therapeutic targets for the treatment of ALS.
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Amyotrophic lateral sclerosis (ALS) is a devastating neu-
rodegenerative disorder characterized by loss of upper
and lower motor neurons. The clinical symptoms of
ALS typically develop at between 50 to 70 years of age,
leading to skeletal muscle weakness including respiratory
failure. The overall median tracheostomy free survival is
2.5 years [1]. Among the genes associated with familial
ALS, mutations in TAR DNA-binding protein-43 (TDP-
43), fused in sarcoma/translocated in liposarcoma (FUS/
TLS), optineurin and SQSTM1, and hexanucleotide re-
peat expansion in C9ORF72 were also identified in spor-
adic ALS cases [2-7]. Wild-type (WT) TDP-43 and FUS/
TLS are predominantly observed in the nucleus by im-
munostaining [8,9]. Besides full-length WT TDP-43, 35-
kDa and 18–26-kDa C-terminal fragments are produced
via caspase-dependent and -independent pathways
[8,10]. The 26-kDa C-terminal TDP-43 fragment aggre-
gated insolubly in the cytoplasm of ALS motor neurons
with ubiquitination and phosphorylation [11,12]. We
previously demonstrated that the 35-kDa C-terminal
fragment functions in the formation of stress granules in
the cytoplasm, which induces mRNA stabilization and
translational arrest against stresses [8]. Similarly, FUS/
TLS mutants linked with ALS, which lacked the nuclear
import activity, demonstrated mislocalization to the
cytoplasm and formed a stress granule-like structure [9].
TDP-43 and FUS/TLS play critical roles in RNA pro-
cessing [13]; however, the association of these RNA-
binding proteins with ALS pathogenesis remains mostly
unknown.
As another specific finding to sporadic ALS, the A-to-I
RNA editing efficiency of mRNA encoding the GluA2 sub-
unit of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA) receptor varied greatly, from 0% to 100%
among the motor neurons of sporadic ALS cases. This
observation was in marked contrast to control motor
neurons, all of which demonstrated 100% editing effi-
ciency [14].
Paraspeckle is known as one of factors which have in-
fluence on edited RNAs [15,16]. Among nuclear bodies
which are important for RNA processing, paraspeckle is
in close proximity to nuclear speckles [17-20]. Based on
bioinformatics analyses, the nuclear-enriched abundant
transcript1 (NEAT1) locus generates two types of non-
coding RNAs (ncRNAs) from the same promoter in the
human genome: 3.7 kb NEAT1_1 (MENε) and 23 kb
NEAT1_2 (MENβ) [21,22]. Notably, NEAT1_2 long
non-coding RNA (lncRNA) is essential for paraspeckle
formation [17-20]. Recent reports, using individual
nucleotide-resolution ultraviolet (UV) cross-linking and
immunoprecipitation (iCLIP), CLIP-seq and photo-
activatable ribonucleoside-enhanced cross-linking and
immunoprecipitation (PAR-CLIP) procedures, displayedthat NEAT1_2 lncRNA was one of RNAs bound by both
TDP-43 and FUS/TLS [23-27].
Previous electron microscopic observations indicated
that the paraspeckle corresponds to a specific structure
of the interchromatin granule-associated zones (IGAZ)
[17,28-30]. In the current model, paraspeckles consist of
NEAT1 ncRNA and more than 40 paraspeckle proteins
including paraspeckle protein-1 (PSP1)/paraspeckle com-
ponent1, p54nrb/non-POU domain-containing octamer-
binding protein (NONO), polypyrimidine tract binding
protein-associated splicing factor (PSF), RNA polymerase
II and other proteins [16,31-34]. Among these proteins,
p54nrb and PSF are core paraspeckle proteins that trigger
the formation of paraspeckles through an interaction with
NEAT1_2 lncRNA.
Building upon these previous findings, we investigated
the association of paraspeckles with TDP-43 and FUS/
TLS in the nucleus and the alteration in paraspeckle for-
mation in spinal motor neurons of ALS patients.
Results
TDP-43 and FUS/TLS are enriched in nuclear paraspeckles
in cultured cells
Characteristics of NEAT1_2 lncRNA and paraspeckle
formation have been elucidated mainly using cultured
cells including HeLa cells [16-20,28-34]. To investigate
the cellular basis for the pathogenesis of ALS, we ini-
tially examined the subcellular localization of WT, mu-
tant and/or truncated forms of TDP-43 and FUS/TLS by
exogenously expressing tagged proteins in HeLa cells.
Both WT and the 35-kDa C-terminal fragment of TDP-43
protein were widely distributed throughout the nucleus;
however, their characteristic aggregates in the nucleus co-
incided with 93.8 ± 10.6% and 89.7 ± 13.9% of the
NEAT1_2 foci, respectively (Figure 1A, B). These findings
mean that almost all NEAT1_2 foci overlap with parts of
TDP-43-forming nuclear aggregates. Similar enrichment
to NEAT1_2 foci was also observed with tagged WT FUS/
TLS (96.9 ± 10.2%; Figure 1A) as well as endogenous
TDP-43 and FUS/TLS (Additional file 1: Figure S1A). By
contrast, the 26-kDa C-terminal fragment of TDP-43
formed few aggregates in the nucleus, and was distributed
throughout both the nucleus and the cytosol, as shown in
a previous article [8], demonstrating a marked lack of af-
finity for NEAT1_2 foci (15.8 ± 17.9%; Figure 1A). Addi-
tionally, ALS-associated TDP-43 mutants and FUS/TLS
mutants were colocalized with NEAT1_2 lncRNA as fre-
quently as WT TDP-43 and WT FUS/TLS (TDP-43A315T:
93.3 ± 12.7%, TDP-43A382T: 98.0 ± 8.2%, FUS/TLSR514S:
95.8 ± 9.3%, and FUS/TLSP525L: 98.4 ± 5.8%; Additional
file 1: Figure S1B, C).
The short form of NEAT1 ncRNA, NEAT1_1, is pro-
duced from the 5′-end of NEAT1. Although an in situ
hybridization probe targeting NEAT 1_1 ncRNA, that is
Figure 1 TDP-43 and FUS/TLS aggregate at nuclear NEAT1_2 foci. A. At 48 hours after transfection with wild-type (WT) and 35-kDa TDP-43
fragment and WT FUS/TLS with the V5 tag at the C terminus, HeLa cells were fixed with 4% paraformaldehyde, hybridized with fluorescein
isothiocyanate (FITC)-labeled RNA probe against NEAT1_2 long non-coding RNA (lncRNA), and double-immunostained with polyclonal anti-FITC
and monoclonal anti-V5 antibodies. Schematic diagram (right) represents the TDP-43 isoforms and FUS/TLS. NLS, Nuclear localization signal; RRM,
RNA recognition motif; C-term, C-terminal domain; GR, glycine-rich motif; NES, nuclear export signal; RGG, arginine-glycine-glycine motif ; ZF, zinc-
finger motif. Dotted lines represent the outline of the nucleus. Scale bars, 10μm. B. The Y-axis shows what percent NEAT1_2 foci is overlapped by
TDP-43 nuclear aggregates in (A). The 26-kDa TDP-43 fragment hardly accumulates in nuclei and lacks affinity for NEAT1_2 foci. Data represent
mean ± s.d. (n = 50 for each transfection of TDP-43 isoforms). *P < 0.0001 (unpaired Student’s t-test).
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S1D (upper), could not precisely distinguish NEAT1_1
foci from NEAT1_2 foci, most NEAT1_1 foci were also
colocalized frequently with nuclear aggregates formed by
WT TDP-43 and WT FUS/TLS (Additional file 1: Figure
S1D, lower).
Another nuclear body, the Cajal body, is related to
RNA metabolism; however, NEAT1_2 foci demonstrated
a complete different distribution from Cajal bodies la-
beled with the marker coilin (Figure 2A, upper). Consist-
ent with a previous report that 40% of TDP-43 nuclear
bodies overlapped with Cajal bodies [35], endogenous
TDP-43 that did not overlap with NEAT1_2 foci over-
lapped with the Cajal bodies separately (Figure 2A,
lower). In light of TDP-43 and FUS/TLS protein
colocalization to NEAT1_2 lncRNA, we tested whetherendogenous TDP-43 and FUS/TLS bound directly to
NEAT1_2 lncRNA. The RNA-protein complex was
immunoprecipitated from UV cross-linked HeLa cells
using polyclonal anti-TDP-43 and anti-FUS/TLS anti-
bodies with stringent washes in high-salt buffer to spoil
protein-protein interactions. The immunoblotting assay
verified specific precipitations by using monoclonal anti-
TDP-43 and anti-FUS/TLS antibodies (Figure 2B). After
bound RNA was isolated, NEAT1_2 lncRNA levels were
quantified by reverse transcription (RT) and polymerase
chain reaction (PCR). NEAT1_2 lncRNA was enriched in
anti-TDP-43 and anti-FUS/TLS immunoprecipitants com-
pared with control IgG immunoprecipitants (Figure 2C).
Paraspeckle formation requires NEAT1_2 lncRNA and
core paraspeckle proteins, which subsequently recruit
other paraspeckle-associated factors and NEAT1_1
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Figure 2 Both TDP-43 and FUS/TLS bind to NEAT1_2 lncRNA and are colocalized with paraspeckle proteins. A. Characterization of
NEAT1_2 foci and Cajal bodies (marker: coilin). After in situ hybridization using DIG-labeled NEAT1_2 probe, untransfected HeLa cells were triple-
labeled with monoclonal IgG1 anti-DIG, monoclonal IgG2b anti-coilin and polyclonal anti-TDP-43 antibodies. Upper: NEAT1_2 lncRNA
demonstrates a different localization pattern from Cajal bodies. Lower: endogenous TDP-43 overlaps with both NEAT1_2 foci and Cajal bodies.
Dotted lines represent the outline of the nucleus. B. Using monoclonal antibodies, full-length TDP-43, FUS/TLS and β-actin bands are shown by
immunoblotting. Immunoprecipitaion (IP) followed by solid washes in high-salt buffer purified the specific protein against each antibody. Protein-
protein interactions were abolished. By combined RNAs, the complexes treated with 254 nm ultraviolet (UV) crosslinking and IP were shifted to
the higher molecule compared to the bands of input without UV treatment. *Non-specific detections of the rabbit IgG heavy chains. C. NEAT1_2
lncRNA directly binds to TDP-43 and FUS/TLS. Following UV crosslinking in HeLa cells, NEAT1_2 RT-PCR bands are detected with the indicated
number of PCR cycles after IP using each antibody. D. Immunofluorescence of HeLa cells, which exogenously expressed WT TDP-43 or FUS/TLS
with the V5 tag, was carried out at 48 hours after transfection. Monoclonal or polyclonal anti-V5 along with anti-PSF or anti-PSP1 antibodies were
used. Dotted lines represent the outline of the nucleus. Scale bars, 10 μm.
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TDP-43 and FUS/TLS formed paraspeckles in cul-
tured cells, immunocytochemistry was performed to
examine the intra-nuclear localization of the para-
speckle proteins, PSF and PSP1. Nuclear aggregates of
TDP-43 and FUS/TLS colocalized with PSF and PSP1
(Figure 2D). Taking these findings together, NEAT1_2foci were considered to form paraspeckles with TDP-
43 and FUS/TLS.
NEAT1_2 lncRNA is not expressed in motor neurons in
control mouse spinal cord
Next, we examined NEAT1_2 distribution in the ner-
vous system of WT control mice in vivo. Some reports
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dant in restricted cells including the epithelial cells of
the esophagus, forestomach, and surface epithelium of
zymogenic region of the stomach in adult mice but not
in embryonic stem cells [36]. No previous reports have
described NEAT1_2 expression in the spinal cord, aged
tissues, or any human tissues. To test the distribution of
NEAT1_1 ncRNA and NEAT1_2 lncRNA in each tissue
including the nervous system in mice, quantitative RT-
PCR was performed using 8-week-old mouse tissue ex-
tracts. NEAT1 ncRNA was highly expressed in lung,
heart, and kidney (Figure 3A) and markedly dominated
by NEAT1_1 expression, consistent with a previousFigure 3 NEAT1_2 lncRNA is not expressed in the nuclei of WT mouse
NEAT1_1 and NEAT1_2 transcripts in tissues of 8-week-old mice are display
B. NEAT1_2 nuclear lncRNA does not appear in the control mouse spinal c
motor neuron in 2-y-old mouse spinal cord. The motor neurons in the ven
features. Dotted lines represent the outline of the nucleus. Arrowheads: co
in situ hybridization (g, h). Lipofuscin in the cytoplasm, which is easily form
asterisk (d, f). A long-path filter was used to distinguish Hoechst from autofreport [36]. Notably, expression levels of NEAT1_1
ncRNA were modest, and NEAT1_2 lncRNA was hardly
detectable in the central nervous system. Therefore, we
further investigated NEAT1_2 distribution specifically in
single spinal motor neurons. In situ hybridization
followed by fluorescent immunohistochemistry (RNA-
FISH) revealed no NEAT1_2 expression in the nuclei of
spinal motor neurons from 8-week-old and 2-y-old mice
(Figure 3B). NEAT1_1 ncRNA was expressed in the
spinal glial cells of both 8-week-old and 2-y-old mice,
and was also expressed at low levels in the spinal motor
neurons of both young and aged mice (Additional file 2:
Figure S2).spinal motor neurons. A. The expression levels of total NEAT1,
ed using quantitative RT-PCR. Data represent mean ± s.d. (n = 3).
ord. (a-c) a motor neuron in 8-week-old mouse spinal cord. (d-f) a
tral horn were distinguished from glial cells by their morphological
lon epithelial cells served as a positive control for NEAT1_2 detected by
ed in aged motor neurons and has autofluorescence, is denoted as an
luorescence. Scale bars, 10 μm.
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spinal cords of human ALS patients
While NEAT1_2 lncRNA interacted with ALS-associated
proteins in human cell lines (Figure 1A and B, Figure 2C
and Additional file 1: Figure S1A), no NEAT1_2 lncRNA
was observed in spinal motor neurons in mice in vivo
(Figure 3B). According to these findings, we hypothesized
that NEAT1_2 lncRNA has a particular role in motor neu-
rons in sporadic ALS patients. To test this hypothesis, the
fresh frozen spinal cords of six sporadic ALS cases (age:
73.2 ± 8.9 y) and six control cases (age: 83.2 ± 4.4 y) were
prepared (Table 1). Contrary to the results in mice
(Figure 3B), RNA-FISH demonstrated that more than
80% of human spinal motor neurons in ALS cases
displayed NEAT1_2 foci in the nuclei (Figure 4A, 5C).
Using sense probe as a negative control, the possibility
that antisense probe against NEAT1_2 lncRNA recognized
other non-specific intranuclear RNAs was excluded in the
human spinal cord (Additional file 3 Figure S3). Parts of
endogenous TDP-43 aggregates in the nucleus coincided
with nearly all NEAT1_2 foci in motor neurons in ALS
cases (Figure 4A), consistent with findings in cultured
cells (Figure 1A and B, Figure 2C and Additional file 1
Figure S1A).
Next, to test whether NEAT1_2 lncRNA in human
motor neurons formed paraspeckle structure, the nuclear
distribution pattern of PSP1 was examined with immuno-
histochemistry and visualized with DAB (Figure 4C). PSP1Table 1 Profiles of individual ALS and control cases in this stu
Patient Sex/Age (y) Disease Duration
of illness
(months)
Duration
respirat
(month
A Female / 66 sporadic ALS 38 26
B Male / 59 sporadic ALS 45 26
C Female / 76 sporadic ALS 39 18
D Male / 76 sporadic ALS 12 -
E Male / 83 sporadic ALS 27 -
F Female / 79 sporadic ALS 31 -
C1 Female / 79 acute myocardial
infarction
- -
C2 Male / 87 Alzheimer’s disease,
lung cancer, hypertension
- -
C3 Female / 86 dementia, acute
myocardial infarction,
hypertension
- -
C4 Female / 81 colon cancer,
post-cerebral infarction
- -
C5 Male / 78 metastatic brain tumor - -
C6 Male / 88 dementia - -
The average ages in ALS and control cases were 73.2 ± 8.9 y and 83.2 ± 4.4 y, respe
the spinal cord. Age, age of the patient at death; Patient A-F, individuals with ALS; Cwas often observed as an aggregated form in the nuclei of
motor neurons as well as surrounding glial cells. In
addition, RNA-FISH demonstrated that PSF, PSP1, and
p54nrb were colocalized with NEAT1_2 foci in the nuclei
of ALS motor neurons (Figure 4D and E, and Additional
file 4: Figure S4). In control cases, more than 60% of
motor neurons demonstrated no NEAT1_2 foci (Figure 4B,
5C); however, the remaining motor neurons contained
NEAT1_2 foci with paraspeckle proteins in the nuclei
(Additional file 4: Figure S4). These results suggest that
paraspeckle proteins have affinity for NEAT1_2 foci in
motor neurons in both ALS and control cases.
Paraspeckles appear predominantly in spinal motor
neurons in the early phase of the pathological process
To test whether paraspeckles in the motor neuron were
formed significantly in sporadic ALS, occurrence rates of
NEAT1_2 lncRNA in human motor neurons were quan-
tified. All motor neurons were regarded as the subjects
of the number count in the ventral horns of several
spinal cord slices at a constant thickness of 14 μm. The
motor neurons were definitively-distinguishable from
surrounding glia cells according to the morphology, spe-
cific structures including lipofuscin, or the size that is
more than approximately 35 μm. To evaluate occurrence
rates of NEAT1_2 lncRNA at the same stage of TDP-43
distribution, we subdivided the pathological stages of ALS
spinal motor neurons into four classes (Table 2, Figure 5A).dy
on
or
s)
TDP-43
cytoplasmic
aggregation
in spinal motor
neurons
Cause of
death
Postmortem
delay until
resection (min)
Number of
spinal motor
neurons
examined
in this study
+ Pneumonitis 82 74
+ empyema 113 104
+ pneumonitis 127 93
+ pneumonitis 112 92
+ pneumonitis 123 143
+ pneumonitis 240 127
- 97 64
- 240 47
- 240 43
- 128 36
- 103 100
- 250 49
ctively. All ALS cases in this study showed TDP-43 cytoplasmic aggregation in
1-C5, normal controls with no neurological disorder affecting the spinal cord.
Figure 4 (See legend on next page.)
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Figure 4 Paraspeckles appear predominantly in spinal motor neurons in ALS. A. RNA-FISH using DIG-labeled NEAT1_2 probe indicates that
NEAT1_2 lncRNA often appears in the nuclei of human motor neurons in sporadic ALS cases. Right panel shows the profile image of fluorescence
intensity of NEAT1_2 lncRNA and TDP-43 along the arrow in the nucleus (ZEN software, Carl Zeiss). Most NEAT1_2 signals overlapped with parts
of aggregated TDP-43 in the nucleus (arrowheads). Dotted lines represent the outline of the nucleus. B. No NEAT1_2 expression is detected in
most motor neurons in control cases. Dotted lines represent the outline of the nucleus. C. A 40-fold magnified view of a spinal motor neuron in
an ALS case is shown with DAB-hematoxylin counterstain using anti-PSP1 antibody. The arrowhead indicates the nucleolus. Arrows indicate PSP1
aggregates in the nucleus. D, E. RNA-FISH using DIG- or FITC-labeled NEAT1_2 probe in the nuclei of ALS motor neurons. PSF ((D), ALS-Pt C),
PSP1 (upper in (E), ALS-Pt D) and p54nrb (lower in (E), ALS-Pt B) overlap with NEAT1_2 foci. Observation at 647 nm wavelength was performed to
rule out autofluorescent signals. Right panels display images on orthogonal sections (ZEN software). Asterisks indicate lipofuscin in the cytoplasm.
Dotted line: outline of the nucleus. Scale bars, 10 μm.
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nucleus. Since TDP-43 is seen in the cytoplasm or the
nucleus of the motor neuron degrades, stage I, II and III
indicate pathological stages in ALS. The nucleus de-
grades but is still recognized at stage I. In stage II, the
nuclear TDP-43 was not recognized any more, however,
the plasma membrane seems still retained. Stage III is
the final stage, where the plasma membrane disappeared
and TDP-43 skein-like inclusions are left behind. ALS
cases demonstrated motor neurons at all pathological
stages, in contrast to control cases in which all motor
neurons were limited to stage 0 (Figure 5B). In overall
counting of the motor neurons in the ventral horn,
there was no significant difference in the NEAT1_2
lncRNA appearance rate between in ALS and control
cases (Additional file 5: Figure S5). Only at stage 0, how-
ever, the occurrence of NEAT1_2 expression in motor
neurons was significantly increased in ALS cases com-
pared to that in control cases (85.6 ± 11.0% and 35.1 ±
22.6%, respectively; Figure 5C). The positive rate of
NEAT1_2 foci in motor neurons was higher at the early
stage of ALS than at the advanced stage (Figure 5D).
This finding suggests that NEAT1_2 lncRNA appeared
preferentially in spinal motor neurons at the earliest
point of ALS.
Characterization of nuclear paraspeckles by electron
microscopy
The nuclear distribution pattern of NEAT1_2 lncRNA in
the human nervous system has not been previously
reported, and its function remains largely unknown. To
observe NEAT1_2 localization in human spinal motor
neurons in detail, electron microscopic analysis com-
bined with in situ hybridization (EM-ISH) was per-
formed. In the spinal cords of human ALS cases,
NEAT1_2 lncRNA was localized to IGAZ in a halo-like
fashion, suggesting that NEAT1_2 lncRNA formed the
characteristic structure of paraspeckles in the nuclei of
spinal motor neurons in ALS cases (Figure 6B-a and -b,
and Additional file 6: Figure S6C), consistent with previ-
ous articles [17,28,30]. By contrast, NEAT1_2-labeled
gold particles around IGAZ were rare in control cases(Figure 6B-c and -d). The IGAZ has been considered to
be identical to a paraspeckle [17,28-30], indicating that the
formation of IGAZ depends on NEAT1_2 lncRNA. IGAZ-
like zone without NEAT1_2 granules in Figure 6B-d sug-
gests that a human motor neuron has a moderately
electron-dense intranuclear structure besides paraspeckles.
Alternatively, independent of NEAT1_2 lncRNA, IGAZ
may exist in the nucleus as a scaffold prior to the recruit-
ment of NEAT1_2 lncRNA to form a complete para-
speckle. NEAT1_1/1_2 probe, detecting both NEAT1_1
ncRNA and NEAT1_2 lncRNA (Additional file 1: Figure
S1D, upper), was observed in the nuclei of spinal motor
neurons in control cases as frequently as those in ALS
cases (Additional file 6: Figure S6A-a, -b, -c and -d). Not-
ably, halo-shaped aggregation patterns formed by
NEAT1_1/1_2 ncRNAs were found throughout nuclei in
ALS spinal motor neurons (Additional file 6: Figure S6A-b)
but were observed rarely in control cases (Additional file
6: Figure S6A-c and -d). Even when diluted NEAT1_1/1_2
probe is used, both central (Additional file 6: Figure S6B-a)
and halo-like (Additional file 6: Figure S6B-b) patterns of
aggregation were observed in a HeLa cell. This suggests
that NEAT1_1 ncRNA may show the central accumula-
tion pattern independently of the IGAZ margin; however,
it could demonstrate the halo-shaped pattern depending
on NEAT1_2 lncRNA. Taken these findings together,
NEAT1_2 lncRNA forms paraspeckles specifically around
IGAZ in the nuclei of motor neurons in ALS cases, which
may affect the distribution of NEAT1_1 ncRNA.
Discussion
In this study, we demonstrated that a lncRNA with GC-
rich sequence, NEAT1_2, is predominantly expressed in
spinal motor neurons in an early phase of the ALS
pathological process. To our knowledge, this report is
the first to indicate a direct association of paraspeckle
formation with a human neurodegenerative disease.
The involvement of abnormalities in functional RNAs
has been reported in the development of various neuro-
degenerative disorders. For example, (CAG)n triplet re-
peats encoding polyglutamine induce spinocerebellar
ataxia type 2; however, when glutamine-coding sequences
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Figure 5 (See legend on next page.)
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Figure 5 Paraspeckle formation is frequently observed in an early phase of ALS. A. A scheme of TDP-43 aggregation patterns in ALS is
presented. Observations detected at 647 nm are added to distinguish the TDP-43-positive signals from autofluorescence produced by lipofuscin
granules in the cytoplasm (shown as an asterisk). Scale bars, 10 μm. B. Stages of motor neurons in sporadic ALS and control cases are shown
according to the definitions in Table 2. The number on the bar graph represents the proportion of motor neurons at each stage in a case.
C. NEAT1_2-positive rates in the spinal motor neurons at stage 0 are indicated (ALS vs. control). Each triangle or circle represents an individual
ALS (Pt) or control (C) patient, respectively. The actual value of percentage in each case is shown in parenthesis. Bars represent the mean ± s.d.;
that is, 85.6 ± 11.0% in ALS cases and 35.1 ± 22.6% in control cases (n = 6 per group). *P<0.001. D. NEAT1_2-positive rates in spinal motor
neurons at each stage are plotted. Mean ± s.d. were 54.0 ± 28.6% at stage I, 15.1 ± 6.1% at stage II, and 0.0 ± 0.0% at stage III (n = 6 per group).
*P<0.05, **P<0.01, ***P<0.001.
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becomes a risk factor for ALS [37]. Moreover, (GGGGCC)
n hexanucleotide repeat expansion in ALS has been de-
scribed in the intron of the C9ORF72 gene recently. Any
ALS cases in the present study did not have (GGGGCC)
hexanucleotide repeat expansion, but previous report
showed that RNA consisting of GGGGCC-expanded re-
peats formed characteristic foci in the nuclei of human
spinal motor neurons [3]. These findings suggest that al-
teration in RNA metabolism may be important for the
ALS pathomechanism in specific nuclear foci including
RNAs with the GC-rich sequence.
Full-length and 35-kDa TDP-43 were retained in
NEAT1_2 foci (Figure 1A, B, and Additional file 1: Figure
S1A), suggesting that the appearance of NEAT1_2
lncRNA may change functions of these TDP-43 proteins
to process RNAs and to form stress granules. By contrast,
NEAT1_2 foci did not retain the 26-kDa fragment of
TDP-43 (Figure 1A, B). Even when NEAT1_2 lncRNA ap-
pears in the nucleus, insoluble 26-kDa TDP-43 with phos-
phorylation is mislocalized to the cytoplasm, consistent
with previous pathological findings [12].
The direct binding of TDP-43 or FUS/TLS to NEAT1_2
lncRNA was verified in Figure 2C. In a recent article,
iCLIP data targeting TDP-43 suggested that NEAT1_2
lncRNA was one of the target RNAs bound predominantly
by TDP-43 in human brain tissue with TDP-43
proteinopathy and cultured cells [23]. According to thisTable 2 Pathological staging of motor neurons in ALS accord
Stage 0 TDP-43 is normally distribu
Stage I The nucleus degradated, an
Stage II The nuclear TDP-43 was so cleared that it wa
Stage III The plasma
TDP-43 distribution
in the nucleus in the cytoplasm
Stage 0 + -
Stage I + +
Stage II ND +
Stage III ND ND
ND, not determined.report, 5% of TDP-43 iCLIPed cDNA was mapped to
lncRNA regions, and TDP-43 demonstrated high binding
affinities to UG-repeat clusters in positions 6,662–6,728
and 21,464–21,544 of NEAT1_2 lncRNA (Additional file
7: Figure S7). Additionally, another recent report pres-
ented proteomic evidence for TDP-43 co-aggregation with
several paraspeckle proteins, suggesting that paraspeckle
formation may have a strong influence on the localization
and function of TDP-43 in the nucleus [38].
Similarly, previous reports indicated that NEAT1_2
lncRNA is one of the RNAs directly bound by FUS/TLS.
Wang et al. demonstrated that FUS/TLS preferentially
interacts with GGUG RNA oligonucleotides [24]. An-
other recent report using iCLIP methods in mouse brain
also revealed that the GGU motif increases the affinity
of FUS/TLS for RNA [25]. Using mouse and human
brain, the latest CLIP-seq data showed enrichment of
the GUGGU motif in FUS/TLS clusters [26]. These re-
ports suggest that UG-rich sequences are the preferred
binding sites of both TDP-43 and FUS/TLS; however,
Rogelj et al. did not mention any overlap between the
sequence specificity of TDP-43 and FUS/TLS [25]. By
contrast, PAR-CLIP procedure revealed that the FUS/
TLS-binding sites frequently involve the SON cluster or
AU-rich stem-loops, unlike the previous reports de-
scribed above [27]. This procedure revealed NEAT1
ncRNA to be a target of both WT and mutant FUS/
TLS. Interestingly, one more binding site in NEAT1ing to TDP-43 distribution
ted within the well-marginated nucleus.
d TDP-43 was also seen in the cytoplasm.
s not recognized.The plasma membrane was still retained.
membrane disappeared.
nuclear membrane plasma membrane
+ +
± +
- +
- -
a c
b
e
d f
BA
NN
E
A
T
1_
2
ALS Control HeLa
Figure 6 NEAT1_2 lncRNA aggregates around the IGAZ forming paraspeckles in motor neurons of the ALS spinal cord. A. Semi-thin
sections (0.5 μm thickness) were observed with toluidine blue staining to identify a motor neuron (arrow), which characteristically includes
lipofuscin (arrowhead) in the cytoplasm. Solid line, outline of the nucleus; dotted line, outline of the cytoplasm. Scale bar, 50 μm. B. Electron
microscopic observation after in situ hybridization using DIG-labeled RNA probe targeting NEAT1_2 lncRNA in the nucleus of a motor neuron in
the spinal cord of an ALS patient (Pt B). The interchromatin granule-associated zone (IGAZ) or IGAZ-like zone is observed as an intermediate electron-
dense cluster. The gold-labeled probe visualizes NEAT1_2 lncRNA as a halo-shaped pattern of aggregations around IGAZ in the nucleus of an ALS
spinal motor neuron (a, b). A control case (C3) demonstrated few NEAT1_2 granules around the IGAZ and/or IGAZ-like zone (c, d). Observation in HeLa
cells is shown as a positive control for the formation of paraspeckle structures (e, f). Scale bars, 200 nm (a-d, f) and 500 nm (e).
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WT FUS/TLS, suggesting the possibility that the affinity
or binding pattern of mutant FUS/TLS may differ from
that of WT FUS/TLS [27]. Here, we found that the
NEAT1_2 sequence possessed at least three similar
stem-loops to the SON cluster that was proposed as a
FUS/TLS-binding site (Additional file 7: Figure S7). In
particular, the most upstream cluster, which starts from
the nucleotide at position 3,440, is highly AU-rich in
content, suggesting that FUS/TLS binds most preferably
to this site of NEAT1_2 lncRNA.
Importantly, the frequency of paraspeckle formation
increased significantly during the early phase of ALS
pathological course (Figure 5C, D). The possibility that
aging simply induced an increase in the level of
NEAT1_2 lncRNA was eliminated based on two obser-
vations. First, NEAT1_2 lncRNA did not appear in the
spinal motor neurons of 2-y-old control mice (Figure 3B),
and second, human control cases in this study were
older than ALS cases by an average of 10 y (Table 1).
The ventral spinal motor neurons include α- and γ-
motor neurons besides interneurons. Here, we counted
all spinal motor neurons on the slides. In the normal
condition, α-motor neurons can be distinguished defin-
itely from γ-motor neurons and interneurons by the size;
that is, α- for more than 35 μm and γ- and interneurons
for less than 35 μm. In this study, however, the α-motor
neurons had degenerated to get smaller, looking like γ-
motor neurons or interneurons. To the best of ourknowledge, any reliable molecular marker has never
been verified to stain α-motor neurons specifically in the
human tissue. Therefore, we could not investigate the
difference of NEAT1_2 lncRNA occurrence according to
the type of neurons in the spinal cord. Developing the
specific human marker of the α-motor neuron, further
investigations are required to determine this point.
This would be also among the first reports to show
EM-ISH images focusing on the nuclei of human motor
neurons. We confirmed that the NEAT1_2 foci in motor
neurons demonstrated characteristics of paraspeckle for-
mation, in which the NEAT1_2 probe revealed a halo-like
appearance around IGAZs (Figure 4C–E and Figure 6B).
By contrast, the NEAT1_1/1_2 probe often demonstrated
a central accumulation pattern, but occasionally formed
the halo-like pattern in the presence of NEAT1_2 lncRNA
(Additional file 6: Figure S6A, B). These results indicate
that NEAT1_2 lncRNA may influence NEAT1_1 ncRNA
localization and possibly function.
As reported previously, Lin28 mRNA transcript and
cationic amino acid transporter 2 transcribed nuclear
RNA with hyper-edited sites are retained in paraspeckles
[15,16], suggesting that RNA editing alterations may dy-
namically change cell fate by retaining RNA in
paraspeckles. Insufficient GluA2 mRNA (Q/R-)editing
efficiencies in motor neurons were identified specifically
in sporadic ALS cases [14]. Translation of a small
amount of the edited GluA2 mRNA in ALS could poten-
tially be suppressed through paraspeckle formation,
Nishimoto et al. Molecular Brain 2013, 6:31 Page 12 of 18
http://www.molecularbrain.com/content/6/1/31while unedited GluA2 mRNA is perhaps predominantly
released from nuclear paraspeckles into the cytoplasm,
causing toxicity to motor neurons.
Both TDP-43 and FUS/TLS are paraspeckle proteins,
which are required for normal paraspeckle formation
through the direct interactions with NEAT1_2 lncRNA.
According to the previous report using cultured cells,
the number and size of paraspeckles were decreased sig-
nificantly by TDP-43 RNAi, and paraspeckle formation
was completely disrupted under the FUS/TLS knock-
down [33]. FUS/TLS also associates with RNA polymer-
ase II, which is another paraspeckle protein [39,40].
RNA polymerase II is not only responsible for poly-
adenylation, but also for determination of the 3′-end-
point in pre-mRNA processing in cooperation with
other paraspeckle proteins, PSF and p54nrb [41,42].
Paraspeckle proteins could induce processing of target
RNAs bound to FUS/TLS or TDP-43 in ALS spinal
motor neurons [43]. The components of the paraspeckle,
including RNA polymerase II, PSF and p54nrb, may pro-
duce RNAs with their 3’UTRs truncated, which could be
resistant to microRNAs. Screening of the target RNAs
assembled in the paraspeckles will be highly informative.
In particular, identification of 3′-end sites or alternative
splicing patterns of target RNAs may be key for future
investigations.Figure 7 Scheme of the pathological alterations in the nucleus of an
mechanisms. NEAT1_2 lncRNA forms paraspeckle structure around IGAZ with
and other paraspeckle proteins including p54nrb, PSF, PSP1 and RNA polymera
motor neuron at an early stage of ALS. PS, paraspeckle; I, inosine at an A-to-I RThe summarized scheme at an early phase of ALS is
shown in Figure 7. Certain stresses may cause NEAT1_2
lncRNA-induced paraspeckle formation in the nucleus,
however, it still remains unknown what mechanism is
involved in the upregulation of NEAT1_2 lncRNA dur-
ing early phase of ALS.
The recent reports have described lncRNA could be
subject to epigenetic regulation, especially histone
methylation, depending on cell types; thus, investigation
of the distribution and levels of H3K4 and H3K27
methylation is required to understand regulation mech-
anism of NEAT1_2 lncRNA in the future [44]. The
paraspeckle retains functional RNA-binding proteins in-
cluding TDP-43, FUS/TLS, and the other paraspeckle
proteins, culminating in an ectopic structure that may
serve as a platform for RNA metabolism associated with
ALS. Hyper-edited RNAs and/or RNAs preferably bound
to paraspeckle component proteins may be captured in
paraspeckles and processed aberrantly prior to export to
the cytoplasm. There is another possibility that para-
speckles with the NEAT1_2 lncRNAs appear under cer-
tain stressful condition during early phase of ALS and
alleviate the toxicity by regulating the specific RNA spli-
cing events and/or the 3’UTR determinations. As the
pathological stage progresses, neuronal degeneration
might occur with the decrease of paraspeckles.ALS motor neuron. NEAT1_2 expression is induced by ALS-associated
NEAT1_1 RNA, RNA-binding proteins consisting of TDP-43 and FUS/TLS,
se II. The right panel represents enlarged illustration of the nucleus of a
NA editing site.
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speckles with RNA-binding proteins will also be highly
informative. In particular, identification of 3′-end pos-
ition or alternative splicing patterns of target RNAs and
regulation in microRNA biogenesis may be key for fu-
ture investigations as described above. Success in this
screening largely depends on technological innovation in
the field of CLIP and RNA sequencing [27,45,46].
For the next step, another investigation into changes
of phenotype after crossing ALS model mice with
NEAT1_2 knockout mice is required to verify, at least in
part, whether the increase in NEAT1_2 lncRNA has a
protective or damaging role in the ALS pathological
pathway. Additionally, NEAT1_2 knock-in mice and hu-
man induced pluripotent stem cells-derived motor neu-
rons under exogenous NEAT1_2 expression should be
characterized.
In conclusion, this study identified the ‘paraspeckle’
formation containing a nuclear lncRNA, NEAT1_2, in
the early phase of ALS, shedding light on novel thera-
peutics for motor neuron degeneration.
Materials and methods
Cell culture and reagents
HeLa human carcinoma cells were maintained in
Dulbecco’s modified Eagle’s medium (Gibco, Grand Is-
land, NY) supplemented with 10% fetal bovine serum as
described previously [8,47]. Transfection was performed
using GeneJuice Transfection Reagent (Novagen, Madison,
WI) according to the manufacturer’s instructions. To
transfect HeLa cells, cells were grown to 60–80% conflu-
ence on 0.001% poly-L-lysine (PLL)-coated coverslips or
8-chamber slides (Chamber slide II, Iwaki Glass, Tokyo,
Japan). Forty-eight hours after transfection, cells were
fixed in 4% paraformaldehyde (PFA) overnight at 4°C for
in situ hybridization or for 10 min at room temperature
for immunofluorescence staining. Cells were washed with
phosphate-buffered saline (PBS), and total RNA was
extracted using TRIzol reagent (Invitrogen, Carlsbad, CA)
for quantitative RT-PCR.
Human tissue frozen samples and animal tissue samples
Human spinal cords were stored at -80°C immediately
after removal from the body. Informed consent was
given by the legal guardians of the patients and all ex-
perimental procedures in this study were carried out in
accordance with the Declaration of Helsinki principles
and with the approval of the Ethics Committees of
School of Medicine, Keio University (no. 20100268),
Tokyo Metropolitan Geriatric Hospital (no. 73), RIKEN
Advanced Science Institute (no. 23-3), and Institute of
Brain and Blood Vessels, Mihara Memorial Hospital (no.
049-01). To quantify RNA expression levels, 8-week-old
C57BL/6 mice were anesthetized with pentobarbital andperfused with PBS, and then each tissue was eluted in
TRIzol followed by RNA extraction and quantitative RT-
PCR. For staining, perfusion was performed with 4%
PFA in PBS. All animal experiments were conducted in
accordance with an animal protocol approved by the La-
boratory Animal Care and Use Committee of Keio Uni-
versity. Tissues were then resected for cryoprotection
with 20% sucrose in PBS and embedded in Tissue-Tek
(Sakura Finetek, Torrance, CA). Sections of human or
mouse dissected tissues (14 μm thick) on PLL-coated
glass slides (Matsunami Glass, Osaka, Japan) were dried
and refixed in 4% PFA overnight at 4°C, followed by im-
munofluorescence staining, in situ hybridization, or im-
munohistochemistry as described below.Antibodies
Among primary antibodies, mouse monoclonal anti-V5
(1:500, R960-25) was purchased from Invitrogen. Rabbit
polyclonal anti-V5 (1:500, A190-120A) and rabbit poly-
clonal anti-FUS/TLS (1:250, A300-302A) were from
Bethyl Labs (Montgomery, TX). Rabbit polyclonal anti-
TDP-43 (1:250, 10782-2-AP) was from Proteintech
(Chicago, IL). These polyclonal antibodies directed
against FUS/TLS and TDP-43 were used for immuno-
chemistry and immunoprecipitation. Mouse monoclonal
antibodies, anti-TDP-43 (1:1,000, H00023435-M01) from
Abnova (Walnut, CA) and anti-FUS/TLS (1:1,000,
4H11, sc-47711) from Santa Cruz Biotechnology (Santa
Cruz, CA), were used for immunoblotting. Rabbit poly-
clonal anti-fluorescein isothiocyanate (FITC) (1:500,
ab19491), mouse monoclonal anti-digoxigenin (DIG)
IgG1 (1:500, H8, ab420), and mouse monoclonal anti-
coilin IgG2b (1:500, IH10, ab87913) were from Abcam
(Cambridge, MA). Mouse monoclonal anti-β-actin
(1:10,000, AC-15, A1978) and anti-PSF (1:200, B92,
P2860) antibodies were from Sigma (St. Louis, MO).
Mouse monoclonal anti-p54nrb (1:200, 3/p54nrb,
611279) was from BD Transduction Laboratories (San
Diego, CA). Rabbit polyclonal anti-PSP1 (1:500) was
generated by T. H. The secondary antibodies used for
immunofluorescence, Alexa Fluor 488 goat anti-rabbit
IgG (A-11034), Alexa Fluor 488 goat anti-mouse IgG1
(A-21121), Alexa Fluor 488 goat anti-mouse IgG2b (A-
21141), Alexa Fluor 555 goat anti-rabbit IgG (A-21429),
Alexa Fluor 555 goat anti-mouse IgG (A-21424), Alexa
Fluor 555 goat anti-mouse IgG1 (A-21127), and Alexa
Fluor 647 goat anti-mouse IgG2b (A-21242), were pur-
chased from Life Technologies (Carlsbad, CA).Vectors
Plasmids containing the V5-tagged series of TDP-43 and
FUS/TLS were kindly provided by Dr. Daisuke Ito (Keio
University) [8,9].
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Fixed cells or tissues on PLL-coated glass slides were
treated with 0.2 N HCl for 20 min, followed by 3 μg/ml
proteinase K (PCR grade; Roche, Indianapolis, IN) at 37°C
for 3 min (in the case of cell samples) or 7 min (in the case
of tissue samples). After acetylation in a solution con-
sisting of 1.5% triethanolamine, 0.25% acetic anhydride,
and 0.25% HCl, the hybridization reaction was carried out
with DIG- or FITC-labeled probes (1 μg/ml) for 16 h at
55°C in hybridization buffer (50% formamide, 2× SSC, 1×
Denhardt’s solution, 5% dextran sulfate, 10 mM ethyl-
enediaminetetraacetic acid (EDTA), and 0.01% Tween 20).
Samples were washed twice at 55°C for 30 min with a so-
lution consisting of 50% formamide, 2× SSC, and 0.01%
Tween 20, and then 10 μg/ml RNase A was added at 37°C
for 1 h in buffer (0.5 M NaCl, 10 mM Tris (pH 8.0), 1 mM
EDTA, and 0.01% Tween 20). They were washed in 2×
SSC wash buffer with 0.01% Tween 20 at 55°C for 30 min,
followed by washing in 0.2× SSC wash buffer with 0.01%
Tween 20 at 55°C for 30 min. After additional washing in
Tris-buffered saline (TBS, pH 7.6) and blocking in a buffer
consisting of blocking reagent (Roche 11096176001), 0.1
M maleate, 0.15 M NaCl, and 0.01% Tween 20 in TBS,
DIG- or FITC-labeled probes were detected by standard
immunohisto-/immunocytochemical procedures using
antibodies against DIG, FITC, and other proteins.
In preparation for DIG- or FITC-labeled RNA probes,
cDNA fragments were amplified using M13 forward
(FW) and reverse (RV) primers with the AV089414 EST
clone as a template for the mouse NEAT1_1/1_2 probe.
cDNA fragments were subcloned into pCRII (Invitrogen)
for the mouse NEAT1_2 probe after amplification using
mNEAT1_2 FW/RV primers with the BAC clone RP23-
209P9 as a template [36]. For the human NEAT1_1/1_2
probe and NEAT1_2 probe, cDNA fragments were
obtained using hNEAT1 FW/RV primers and hNEAT1_2
FW/RV primers, respectively, using a cDNA library de-
rived from HeLa cells as a template and were subcloned
into pCRII-TOPO (Invitrogen) and pGEM-T Easy vec-
tors (Promega, Madison, WI). Each primer is shown in
Additional file 8: Table S1. Both antisense and negative
control sense RNA probes were prepared using a DIG/
FITC RNA labeling mix (1277073/1685619, Roche),
RNasin Plus RNase Inhibitor (N2611, Promega), and T3,
T7 or SP6 RNA polymerase (P2083/ P2075/P1085, re-
spectively, Promega) according to the manufacturer’s in-
structions. The usability of each probe was finally
characterized by Northern blot.
CLIP assay
CLIP assay was performed as described previously
[48,49]. Briefly, HeLa cells were UV cross-linked at 254
nm (UV-B) with 600 J/cm2 in a UV Stratalinker 1800
crosslinker (Stratagene, La Jolla, CA); lysed in washbuffer containing 1× PBS, 0.1% sodium dodecyl sulfate
(SDS), 0.5% deoxycholate, and 0.5% NP-40; supplemented
with 0.015 U/μl RNasein Plus (N261, Promega) and RQ
RNase-Free DNase (M610A, Promega); and immuno-
precipitated for 2 h at 4°C with 5 μg polyclonal anti-TDP
-43, anti-FUS/TLS, and rabbit IgG control (AB-105-C,
R&D Systems, Minneapolis, MN) antibodies bound in ad-
vance to Dynabeads Protein G (100.04 D, Invitrogen).
Immunoprecipitated materials were washed as follows:
twice with wash buffer described above for 5 min; twice
with 5× PBS, 0.1% SDS, 0.5% deoxycholate, and 0.5% NP-
40 for 5 min (using high-salt wash buffer to completely re-
move indirect protein-RNA interactions); and twice with
50 mM Tris-HCl (pH 7.4), 10 mM MgCl2, and 0.5% NP-
40 for 5 min. The immunoprecipitated protein-bead com-
plexes were removed from RNA by proteinase K
(13731196, Roche) digestion. RNA was then isolated by
phenol/chloroform extraction and treated again with
DNase I before the RT reaction was performed as de-
scribed below. Bound RNAs were evaluated by PCR
assay using the qhNEAT1_2 FW/RV primers listed in
Additional file 8: Table S1. The PCR reaction was
performed in a 50 μl reaction mixture containing 0.2 μM
of each primer, 0.25 mM dNTP mix (Takara, Otsu, Japan),
5 μl 10× PCR buffer, and 1 μl Advantage 2 Polymerase
mix (639201, Clontech, Mountain View, CA). PCR ampli-
fication began with a denaturation step at 95°C for 1 min,
followed by 25, 33, or 40 cycles of denaturation at 95°C
for 10 s, annealing at 64°C for 30 s, and extension at 68°C
for 30 s.
Immunoblotting
Cells and UV cross-linked immunoprecipitates after
stringent washes with the high-salt wash buffer were
lysed in cold lysis buffer (50mM Tris–HCl, pH 7.4, 150
mM NaCl, 0.5% Nonidet P-40, 0.5% sodium deoxy-
cholate, 0.25% SDS, 5mM EDTA and Complete, EDTA-
free Protease Inhibitor Cocktail Tablets (1873580,
Roche)). The input cell lysate was briefly sonicated and
lysed samples were separated via reducing SDS-PAGE
on a 4–20% Tris-glycine gradient gel (Invitrogen). Pro-
teins were then transferred onto a polyvinylidene
difluoride membrane (Millipore, Billerica, MA). The
membrane was incubated with primary antibodies,
followed by horseradish peroxidase-conjugated secondary
antibodies. Proteins were visualized using electro-
chemiluminescence (ECL) detection reagent (GE Health-
care, Milwaukee, WI) and an ImageQuant LAS 4000
digital imaging system (GE Healthcare).
Immunofluorescence
Fixed cells or tissues were permeabilized in 0.2% Triton
X-100 for 10 min. After blocking for nonspecific binding
in TNB blocking buffer (NEL702, Perkin Elmer,
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antibodies, washed three times in PBS with 0.1% Tween-
20, and incubated with secondary antibodies described
above. Immunofluorescent images were obtained using a
confocal microscope LSM700 (Carl Zeiss, Oberkochen,
Germany).
Immunohistochemistry
Paraffin-embedded tissue sections were deparaffinized,
pretreated with 0.3% H2O2 for 30 min, boiled in citrate
solution (pH 6.0), and reacted with TNB blocking buffer,
anti-PSP1 primary antibody, and biotin-conjugated don-
key anti-rabbit IgG secondary antibody (711-066-152,
Jackson Immunoresearch, West Grove, PA). Signals were
enhanced with the Vectastain ABC kit (Vector Labora-
tories, Burlingame, CA). Visualization was performed
with DAB (Wako, Osaka, Japan) and 1:20,000 dilution of
saturated H2O2 to observe PSP1 immunopositivity in
the nucleus of the motor neuron. The figures were ex-
amined using AxioVision imaging software (Carl Zeiss).
Quantitative RT-PCR
Total RNA was extracted from TRIzol reagent-treated
samples using an RNAspin Mini RNA Isolation kit
(74106, Qiagen, Germantown, MD) after chloroform/
phenol extraction [14]. After treatment with DNase I,
RT was carried out using Ready-To-Go You-Prime First-
Strand Beads (27-9264-01, GE Healthcare) according to
the manufacturer’s instructions. The resultant cDNA
was measured by quantitative PCR with SYBR Premix
Ex Taq (Perfect Real Time) (RR041A, Takara) in the
Mx3000p system (Stratagene) using Rox as a reference
and the following primers: qmNEAT1 FW/RV for mouse
NEAT1_1/1_2 cDNA, qmNEAT1_2 FW/RV for mouse
NEAT1_2 cDNA, and qmActin FW/RV for mouse β-actin
cDNA. All primer sequences are listed in Additional file 8:
Table S1. Primers for PCR to detect NEAT1_1 cDNA
alone could not be designed; thus, the amount of
NEAT1_1 expression was calculated by subtracting the
copy number of NEAT 1_2 cDNA from that of total
NEAT1 cDNA. The reaction was performed at 95°C for
10 min, followed by 50 cycles at 95°C for 30 s, 60°C for 1
min, and 72°C for 30 s after serial dilutions ranging from
1010, 108, 106, 104, 102, to 101 copies per 1 μl of DNA solu-
tion were prepared as standard samples by subcloning
each PCR product into the Zero Blunt TOPO PCR Clon-
ing Kit (K2800, Invitrogen).
EM-ISH
For transmission electron microscopic analysis, frozen
sections of the human spinal cord and HeLa cells were
used. As mentioned above, in situ hybridization with DIG-
labeled RNA probes targeting NEAT1_2 or NEAT1_1/1_2
was performed, which included proteinase K digestion at37°C for 5 min for human tissue sections and 50 s for
HeLa cells. Samples were incubated for 72 h at 4°C with
mouse anti-DIG (1:250) and rabbit anti-PSP1 (1:250)
primary antibodies. Following washes in 0.005% saponin
containing 0.1 M phosphate buffer (PB) for 2 h, samples
were incubated for 24 h at 4°C with fluorescence- and
Nanogold-conjugated anti-mouse secondary antibodies
(1:100, Life Technologies) along with fluorescence-
conjugated anti-rabbit secondary antibodies (1:800, Life
Technologies). After another wash with PB, samples were
observed with LSM700. Samples were fixed with 2.5%
glutaraldehyde for 10 min at 4°C, followed by 10 min of
enhancement with the HQ-Silver kit (Nanoprobes, Stony
Brook, NY) in a dark room. After 90 min of additional
fixation with 1.0% osmium tetroxide, samples were
dehydrated through ethanol, acetone and QY1, and em-
bedded in epon. Ultrathin sections of HeLa cells and motor
neurons in the human spinal cord were prepared at a thick-
ness of 70 nm and stained with uranyl acetate and lead
citrate for 10 min each. The sections were observed using
a JEOL 1230 transmission electron microscope (JEOL,
Tokyo, Japan) and photographed with Digital Micrograph
3.3 (Gatan Inc., Warrendale, PA). Sections of 0.5 μm thick-
ness including the spinal ventral horn were simultaneously
stained with 0.3% toluidine blue to identify the resected
area for observation. Images of toluidine blue staining
were examined using AxioVision software (Carl Zeiss).Statistical analyses
Statistical significance was determined using unpaired
Student’s t-test. P < 0.05 was considered statistically sig-
nificant. Error bars represent the standard deviation of
the mean.Additional files
Additional file 1: Figure S1. Colocalization of endogenous and mutant
forms of TDP-43 and FUS/TLS with NEAT1_2 lncRNA. A. HeLa cells were
double-immunostained with polyclonal antibody against endogenous TDP-
43 or FUS/TLS and monoclonal anti-DIG antibody after in situ hybridization
using DIG-labeled NEAT1_2 probe. Endogenous TDP-43 and FUS/TLS
colocalize with NEAT1_2 foci. B, C. At 48 hours after transfection with
amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 and FUS/TLS with
the V5 tag at the C-terminus, HeLa cells were hybridized with FITC-labeled
probe against NEAT1_2 lncRNA, and immunolabeled with monoclonal anti-
V5 and polyclonal anti-FITC antibodies. Aggregates formed by mutant TDP-
43 and mutant FUS/TLS in the nucleus also overlap with NEAT1_2 foci. The
overlapping rate among NEAT1_2 foci with aggregates formed by mutant
TDP-43 or mutant FUS/TLS did not differ from that with aggregates formed
by wild-type (WT) TDP-43 or FUS/TLS. Data represent mean ± s.d. The
frequency was quantitatively evaluated in 50 cells for each transfection.
Dotted lines represent the outline of the nucleus. D. Characterization of
NEAT1_1 foci. Scheme of human NEAT1_1 and NEAT1_2 ncRNAs is shown
at the top. Blue bars indicate probe target sites (positions 3,512–5,074 in
NEAT1_2 lncRNA sequence for NEAT1_1/1_2 probe and position 14,865–
15,472 for NEAT1_2 probe). At 48 hours after transfection with WT TDP-43
and WT FUS/TLS with the V5 tag at the C terminus, fixed HeLa cells were
hybridized with FITC-labeled NEAT1_1/1_2 probe and double-labeled with
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represent the outline of the nucleus. Scale bars, 10 μm.
Additional file 2: Figure S2. NEAT1_1 ncRNA is observed in the nuclei
of glial cells and motor neurons in the mouse spinal cord by RNA-FISH.
Left column: 8-week-old mouse spinal cord; right column: 2-y-old mouse
spinal cord. Arrowheads: NEAT1_1 ncRNA in the nuclei of glial cells;
arrows: faint labeling of NEAT1_1 ncRNA in the nuclei of motor neurons;
dotted line: outline of the nucleus. Asterisks denote lipofuscin with
autofluorescence in the cytoplasm. A long-path filter was used to
distinguish Hoechst staining from autofluorescence. Scale bars, 10 μm.
Additional file 3: Figure S3. Sense probe designed as a negative
control of NEAT1_2 antisense probe in this study. The sense probe was
synthesized by using the same template vector as that for the antisense
probe against NEAT1_2 lncRNA and a RNA polymerase opposite to that
used in synthesis of the antisense probe. Non-specific hybridization with
the sense probe was not seen in human motor neurons. * Lipofuscin in
the motor neuron. Scale bars, 10 μm.
Additional file 4: Figure S4. NEAT1_2 lncRNA is often colocalized with
nuclear PSF and PSP1 in ALS and control cases. RNA-FISH using DIG- or
FITC-labeled NEAT1_2 probe in the nuclei of the spinal motor neurons in
ALS and control cases. The right-most images show overlaps of NEAT1_2
foci and paraspeckle proteins on orthogonal sections (using ZEN software,
Carl Zeiss). Dotted line: outline of the nucleus. Scale bars, 10 μm.
Additional file 5: Figure S5. Occurrence rates of NEAT1_2 lncRNA foci
in all stages of ventral motor neurons in ALS and control cases. Totally
without classification, there was no difference in occurrence rates of
NEAT1_2 lncRNA in all stages of motor neurons between in ALS and
control cases (40.2 ± 15.5 % vs. 35.1 ± 22.6 %, respectively, P=0.328).
Additional file 6: Figure S6. A. Electron microscopic observations
combined with in situ hybridization (EM-ISH) in the nuclei of human
spinal motor neurons using the NEAT1_1/1_2 probe (ALS and control).
Using the NEAT1_1/1_2 probe, both the halo pattern of aggregation
(arrows in b, e, f) and the other pattern of aggregates extending into the
central portion are observed in an ALS case (a, b) and HeLa cells (e, f).
Meanwhile, the halo-shaped accumulation pattern is hardly observed in a
control case (c, d). HeLa cells are used as a positive control for paraspeckle
formation. Scale bars, 500 nm (a, b, e, f) and 200 nm (c, d). B. Electron
microscopic observations in a HeLa cell using diluted NEAT1_1/1_2 probe.
Even when diluted NEAT1_1/1_2 probe is used, both central (a) and halo-
like (b) patterns of aggregation are observed in a HeLa cell. This suggests
that NEAT1_1 RNA may show the central accumulation pattern
independently of the IGAZ margin. The lower panels are magnified images
of the (a) and (b) regions. Scale bars, 5 μm (upper) and 200 nm (lower, a
and b). C. EM-ISH observations in a spinal motor neuron of another case of
ALS (Pt C) using the NEAT1_2 probe. Another case of ALS also shows halo-
like patterns of aggregation labeled with the NEAT1_2 probe in a spinal
motor neuron, similar to Pt B in Figure 6B-a and -b. Scale bars, 100 nm.
Additional file 7: Figure S7. Prediction of FUS/TLS- and TDP-43-
binding sites in NEAT1 ncRNA. Black arrowheads represent the positions
(3,440–3,460; 10,108–10,127; and 18,316–18,335) where the proposed
binding sites similar to the SON cluster are located in the NEAT1_2
genome, predicted by PAR-CLIP as preferred binding sites of FUS/TLS
(ref. [27] in the text). Screening was carried out under the conditions of
stem size = 6 bp and loop size = 7–9 nucleotides. Green nucleotides
comprise conventional stem structures, and red nucleotides represent
typical non-Watson-Crick base pairs proposed for the SON cluster. The
yellow boxes (in positions 6,662–6,728 and 21,464–21,544) represent the
binding sites of TDP-43, which have been predicted by TDP-43 iCLIP in a
previous report (ref. [23] in the text).
Additional file 8: Table S1. Oligonucleotides used in this study.
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